Legal Representation
Attorney
Christopher D. Olszyk, Jr.
USPTO Deadlines
Application History
36 eventsDate | Code | Type | Description | Documents |
---|---|---|---|---|
Mar 20, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
Mar 20, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
Aug 11, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Aug 9, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
Aug 9, 2022 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
Aug 9, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 5, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 3, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
Feb 3, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
Feb 3, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 12, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Aug 10, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
Aug 10, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
Aug 10, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Feb 11, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
Feb 9, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
Feb 9, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
Feb 9, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
Aug 11, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
Jun 17, 2020 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
Jun 17, 2020 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
Jun 17, 2020 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
Jun 16, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
Jun 16, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
May 27, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
May 13, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
May 13, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
May 13, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
May 12, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
May 6, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
Jan 30, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
Jan 30, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Jan 30, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
Jan 29, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
Oct 30, 2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Oct 28, 2019 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Diagnostic reagents for clinical or medical laboratory use; diagnostic reagents for scientific or research use; reagents for scientific or medical research use
Class 005
Chemical reagents for medical or veterinary purposes; clinical medical reagents; diagnostic reagents for medicinal use; medical diagnostic reagents; reagents for medical use
Class 010
Liquid and tissue biopsy tests and devices, namely, medical instruments for use in performing biopsies and medical diagnostic apparatus for testing biomarkers; cancer screening tests and devices, namely, medical devices for detecting cancer; blood testing apparatus for cancer diagnosis; medical testing devices for tumor diagnosis
Class 042
Providing reagent sample testing and diagnostic services for others in the fields of science and research related thereto
Class 044
Providing cancer screening services
Additional Information
Translation
The wording "APERIGEN" has no meaning in a foreign language.
Classification
International Classes
001
005
010
042
044